shorten the paragraph, to 50 words, "All 206 individuals were randomized with 69% being female and the median age being 58 years (Interquartile Range: 49-64 years). The median baseline HbA1c was 64 mmol/mol (Interquartile Range: 45-88 mmol/mol), or 7.9% (Interquartile Range: 6.4-10.2%). Primary outcome data was collected from 79 participants in the intervention group and 80 in the control group. Some participants were lost to follow-up due to death (1 person), stroke (1 person), or being unreachable or unavailable (47 people). Both groups showed a decrease in HbA1c levels. The intervention group had a reduction of -9 mmol/mol (95% Confidence Interval: -13 to -5 mmol/mol), or -0.9% (95% Confidence Interval: -1.2% to -0.51%). The control group had a reduction of -3 mmol/mol (95% Confidence Interval: -6 to 1 mmol/mol)